These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790 [TBL] [Abstract][Full Text] [Related]
3. The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process. Sebastian-Valverde M; Pasinetti GM Cells; 2020 Jun; 9(6):. PubMed ID: 32604771 [TBL] [Abstract][Full Text] [Related]
4. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease. Lee S; Suh GY; Ryter SW; Choi AM Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms regulating NLRP3 inflammasome activation. Jo EK; Kim JK; Shin DM; Sasakawa C Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800 [TBL] [Abstract][Full Text] [Related]
6. Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome. Mastrocola R; Aragno M; Alloatti G; Collino M; Penna C; Pagliaro P Curr Med Chem; 2018; 25(11):1294-1310. PubMed ID: 28403789 [TBL] [Abstract][Full Text] [Related]
7. The NLRP3 Inflammasome as a Pharmacological Target. Marchetti C J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445 [TBL] [Abstract][Full Text] [Related]
8. The NLRP3 inflammasome in acute myocardial infarction. Toldo S; Abbate A Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812 [TBL] [Abstract][Full Text] [Related]
9. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases. Zhong Z; Sanchez-Lopez E; Karin M Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797 [TBL] [Abstract][Full Text] [Related]
11. NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection. Segovia JA; Chang TH; Winter VT; Coalson JJ; Cagle MP; Pandranki L; Bose S; Baseman JB; Kannan TR Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061706 [No Abstract] [Full Text] [Related]
12. Role and mechanism of the nod-like receptor family pyrin domain-containing 3 inflammasome in oral disease. Lv K; Wang G; Shen C; Zhang X; Yao H Arch Oral Biol; 2019 Jan; 97():1-11. PubMed ID: 30315987 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria-Endoplasmic Reticulum Contact Sites Mediate Innate Immune Responses. Misawa T; Takahama M; Saitoh T Adv Exp Med Biol; 2017; 997():187-197. PubMed ID: 28815531 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of NLRP3 priming in inflammaging and age related diseases. Gritsenko A; Green JP; Brough D; Lopez-Castejon G Cytokine Growth Factor Rev; 2020 Oct; 55():15-25. PubMed ID: 32883606 [TBL] [Abstract][Full Text] [Related]
15. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970 [TBL] [Abstract][Full Text] [Related]
16. [Regulation of the NLRP3 inflammasome]. Groslambert M; Py BF Med Sci (Paris); 2018 Jan; 34(1):47-53. PubMed ID: 29384096 [TBL] [Abstract][Full Text] [Related]
17. The NLRP3 inflammasome in kidney disease and autoimmunity. Hutton HL; Ooi JD; Holdsworth SR; Kitching AR Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059 [TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611 [TBL] [Abstract][Full Text] [Related]
19. AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging. Cordero MD; Williams MR; Ryffel B Trends Endocrinol Metab; 2018 Jan; 29(1):8-17. PubMed ID: 29150317 [TBL] [Abstract][Full Text] [Related]
20. NLRP3: A Novel Mediator in Cardiovascular Disease. Zhou W; Chen C; Chen Z; Liu L; Jiang J; Wu Z; Zhao M; Chen Y J Immunol Res; 2018; 2018():5702103. PubMed ID: 29850631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]